116 related articles for article (PubMed ID: 38508474)
1. PlexinA1 promotes gastric cancer migration through preventing MICAL1 protein ubiquitin/proteasome-mediated degradation in a Rac1-dependent manner.
Ye F; Xia T; Zhao M; Zhao W; Min P; Wang Y; Wang Q; Zhang Y; Du J
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167124. PubMed ID: 38508474
[TBL] [Abstract][Full Text] [Related]
2. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway.
Gu H; Li Y; Cui X; Cao H; Hou Z; Ti Y; Liu D; Gao J; Wang Y; Wen P
Biochem Pharmacol; 2022 Jan; 195():114870. PubMed ID: 34902339
[TBL] [Abstract][Full Text] [Related]
3. MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours.
McGarry DJ; Armstrong G; Castino G; Mason S; Clark W; Shaw R; McGarry L; Blyth K; Olson MF
Cancer Lett; 2021 Oct; 519():226-236. PubMed ID: 34314753
[TBL] [Abstract][Full Text] [Related]
4. NEDD9 Facilitates Hypoxia-Induced Gastric Cancer Cell Migration via MICAL1 Related Rac1 Activation.
Zhao S; Min P; Liu L; Zhang L; Zhang Y; Wang Y; Zhao X; Ma Y; Xie H; Zhu C; Jiang H; Du J; Gu L
Front Pharmacol; 2019; 10():291. PubMed ID: 31019460
[TBL] [Abstract][Full Text] [Related]
5. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma.
Yang Y; Ye F; Xia T; Wang Q; Du J
BMC Cancer; 2022 Dec; 22(1):1355. PubMed ID: 36575439
[TBL] [Abstract][Full Text] [Related]
6. MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells.
Deng W; Wang Y; Gu L; Duan B; Cui J; Zhang Y; Chen Y; Sun S; Dong J; Du J
BMC Cancer; 2016 Jul; 16():489. PubMed ID: 27430308
[TBL] [Abstract][Full Text] [Related]
7. MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway.
Deng W; Wang Y; Zhao S; Zhang Y; Chen Y; Zhao X; Liu L; Sun S; Zhang L; Ye B; Du J
J Cell Mol Med; 2018 Jun; 22(6):3108-3118. PubMed ID: 29524295
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the role of MICAL1 in pan-cancer using integrated bioinformatics and experimental approaches.
Li C; Xiao Y; Kong J; Lai C; Chen Z; Li Z; Xie W
Cell Adh Migr; 2024 Dec; 18(1):1-17. PubMed ID: 38555517
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
11. Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.
Qu H; Sun H; Wang X
Cell Physiol Biochem; 2018; 48(4):1457-1467. PubMed ID: 30064133
[TBL] [Abstract][Full Text] [Related]
12. Silencing Rac1 and Prex1 Inhibit Epithelial-Mesenchymal Transition in Human Gastric Cancer Cells Induced by Transforming Growth Factor-β1.
Gao X; Lin X; Lin M; Lan Y; Wang Y; Wu R; Li J; Huang C; Zhong D
Turk J Gastroenterol; 2023 Sep; 34(9):975-981. PubMed ID: 37434402
[TBL] [Abstract][Full Text] [Related]
13. CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis in vitro.
Cheng X; Wang X; Wu Z; Tan S; Zhu T; Ding K
FEBS Open Bio; 2019 Jun; 9(6):1097-1108. PubMed ID: 30974047
[TBL] [Abstract][Full Text] [Related]
14. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
[TBL] [Abstract][Full Text] [Related]
15. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells.
Dai YH; Tang YP; Zhu HY; Lv L; Chu Y; Zhou YQ; Huo JR
Dig Dis Sci; 2012 May; 57(5):1253-60. PubMed ID: 22350782
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CASC19 promotes gastric cancer progression through preventing CREB1 protein ubiquitin/proteasome-dependent degradation.
Wang S; Qiao C; Li J; Liu S; Li P
Carcinogenesis; 2023 May; 44(3):209-220. PubMed ID: 36651836
[TBL] [Abstract][Full Text] [Related]
17. MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway.
Cai K; Deng L; Zheng D; Li L; He Z; Yu C
J Transl Med; 2022 Nov; 20(1):528. PubMed ID: 36371204
[TBL] [Abstract][Full Text] [Related]
18. MICAL1 (molecule interacting with CasL 1) protects oligodendrocyte cells from oxidative injury through regulating apoptosis, autophagy in spinal cord injury.
Xu C; Mao L; Tian H; Lin S; Zhao X; Lin J; Li D; Li X; Mei X
Neurosci Lett; 2021 Apr; 750():135712. PubMed ID: 33647394
[TBL] [Abstract][Full Text] [Related]
19. Pannexin 1 Mediates Gastric Cancer Cell Epithelial-Mesenchymal Transition via Aquaporin 5.
Ying W; Zheng K; Wu Y; Wang O
Biol Pharm Bull; 2021 Aug; 44(8):1111-1119. PubMed ID: 34135208
[TBL] [Abstract][Full Text] [Related]
20. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma.
Yoon C; Cho SJ; Chang KK; Park DJ; Ryeom SW; Yoon SS
Mol Cancer Res; 2017 Aug; 15(8):1106-1116. PubMed ID: 28461325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
